Expression of GAD65 and Islet Cell Antibody (ICA512) Autoantibodies among Cytoplasmic ICA+ Relatives Is Associated with Eligibility for the Diabetes Prevention Trial-Type 1

Diabetes

Volumn 50, Issue 8, 2001, Pages 1735-1740

  Yu, Liping ^a   Cuthbertson, David D ^b   Maclaren, Noel ^c   Jackson, Richard ^d   Palmer, Jerry P ^e   Orban, Tihamer ^d   Eisenbarth, George S ^a,f   Krischer, Jeffrey P ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d HARVARD UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; HLA DQ ANTIGEN; ICA512 AUTOANTIBODY; INSULIN; INSULIN ANTIBODY; ISOENZYME;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CHILD; CLINICAL TRIAL; ETHNIC GROUP; FAMILY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT SELECTION; PREDICTION AND FORECASTING; PRESCHOOL CHILD; REPRODUCIBILITY; SECRETION; UNITED STATES;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; ETHNIC GROUPS; FAMILY; FEMALE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; INFANT; INSULIN; INSULIN ANTIBODIES; ISOENZYMES; MALE; MIDDLE AGED; MULTICENTER STUDIES; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 0035430662     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.8.1735     Document Type: Article

References (29)

1. Bingley PJ, Bonifacio E, Gale EAM: Can we really predict IDDM? Diabetes 42:213-220, 1993
2. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
3. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149, 1990
4. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JL: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323:1167-1172, 1990
5. Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander VP, Notkins A, Krischer J: Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (type 1) diabetes in relatives. J Autoimmun 12:279-287, 1999
6. Greenbaum CJ, Sears KL, Kahn SE, Palmer JP: Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes. Diabetes 48:170-175, 1999
7. Schatz D, Krischer J, Horne G, Riley W, Spillar R, Silverstein J, Winter W, Muir A, Derovanesian D, Shah S, Malone J, Maclaren N: Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 93:2403-2407, 1994
8. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS: Life table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 38:1320-1325, 1989
9. Ziegler A-G, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes 48:460-468, 1999
10. Colman PG, McNair P, Margetts H, Schmidli RS, Werther GA, Alford FP, Ward GM, Tait BD, Honeyman MC, Harrison LC: The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing. Med J Aust 169:81-84, 1998
11. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM: Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710, 1997
12. 65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40:95-99, 1997
13. Marshall MO, Hoyer PE, Petersen JS, Hejnaes KR, Genovese S, Dyrberg T, Bottazzo GF: Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies. J Autoimmun 7:497-508, 1994
14. 3H recombinant human ligands. J Immunol Methods 186:89-99, 1995
15. Gianani R, Rabin DU, Verge CF, Yu L, Babu S, Pietropaolo M. Eisenbarth GS: ICA512 autoantibody radioassay. Diabetes 44:1340-1344, 1995
16. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS. participating laboratories: Combined use of autoantibodies (IA-2ab, GADab, IAA, ICA) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866, 1998
17. Schmidli RS, Colman PG, Bonifacio E, participating laboratories: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the Second International GADAb Workshop. Diabetes 44:636-640, 1995
18. Greenbaum C, Palmer JP, Kuglin B, Kolb H, participating laboratories: Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab 74:1040-1044, 1992
19. Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Åkerblom HK, Knip M, Childhood Diabetes in Finland Study Group: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population-based study. J Clin Invest 101:327-336, 1998
20. Pietropaolo M, Peakman M, Pietropaolo SL, Zanone MM, Foley TP Jr, Becker DJ, Trucco M: Combined analysis of GAD65 and ICA512 (IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J Autoimmun 11:1-10, 1998
21. Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Böhm BO, Richter W: Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 46:565-571, 1997
22. 65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 37:917-924, 1994
23. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte M-T, Bottazzo G-F, Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
24. Yu L, Rewers M, Gianani R, Kawasaki E, Zhang Y, Verge C, Chase P, Klingensmith G, Erlich H, Norris J, Eisenbarth GS: Anti-islet autoantibodies develop sequentially rather than simultaneously. J Clin Endocrinol Metab 81:4264-4267, 1996
25. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, Eisenbarth GS: Early expression of anti-insulin autoantibodies of man and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 97:1701-1706, 2000
26. Vardi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Rabizadeh A, Riley WJ, Maclaren NK, Eisenbarth GS, Soeldner JS: Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type 1 diabetes mellitus. Diabetes 36:1286-1291, 1987
27. Bingley PJ, Colman P, Eisenbarth GS, Jackson RA, McCulloch DK, Riley WJ, Gale EAM: Standardization of IVGTT to predict IDDM. Diabetes Care 15:1313-1316, 1992
28. Pugliese A, Kawasaki E, Zeller M, Yu L, Babu S, Solimena M, Moraes CT, Pietropaolo M, Friday RP, Trucco M, Ricordi C, Allen M, Noble JA, Erlich HA, Eisenbarth GS: Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. J Clin Endocrinol Metab 84:1722-1728, 1999
29. Robert JJ, Deschamps I, Chevenne D, Roger M, Mogenet A, Boitard C: Relationship between first-phase insulin secretion and age: HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients. Diabetes Care 14:718-723, 1991